By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Galapagos (GLPG.BR) Release: Successful Completion Of End-Of-Phase 2 FDA And European Medicines Agency Consultations In Rheumatoid Arthritis (RA) 5/25/2016 9:15:56 AM
Pfizer (PFE) Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For TRUMENBA (Meningococcal Group B Vaccine) 5/20/2016 8:21:23 AM
WuXi AppTec's Pharmaceutical Development Service And Analytical Service Passes European Medicines Agency Inspection 5/12/2016 8:11:58 AM
European Medicines Agency/CHMP Adopts Positive Opinion For ITM's EndolucinBeta 5/10/2016 11:10:52 AM
AbbVie (ABBV) Release: European Medicines Agency Issues Positive Opinion For The Use Of IMBRUVICA (Ibrutinib) As A First-Line Treatment For Chronic Lymphocytic Leukemia Patients 4/29/2016 7:32:15 AM
European Medicines Agency Grants Accelerated Assessment Of Marketing Authorization Application For Xilonix, XBiotech USA (XBIT)h’s True Human Therapeutic Antibody Treatment For Advanced Colorectal Cancer 4/4/2016 8:17:07 AM
European Medicines Agency Validates Bristol-Myers Squibb (BMY)'s Application For Opdivo (Nivolumab) For The Treatment Of Classical Hodgkin Lymphoma Patients 3/31/2016 10:57:36 AM
Kamada Ltd. (KMDA) Submits Marketing Authorization Application With European Medicines Agency For Its Proprietary Inhaled Alpha-1 Antitrypsin To Treat Alpha-1 Antitrypsin Deficiency 3/28/2016 9:23:26 AM
Eiger Biopharma Granted Orphan Medicinal Product Designation For Ubenimex In Pulmonary Arterial Hypertension By European Medicines Agency 3/28/2016 6:13:30 AM
Pfizer (PFE) Announces European Medicines Agency Accepted For Review Its Marketing Authorization Application For XELJANZ (Tofacitinib Citrate) For The Treatment Of Moderate To Severe Rheumatoid Arthritis 3/24/2016 10:12:35 AM